Samsung Biologics CEO John Rim browses Samsung Electronics’ exhibit at CES 2026 in Las Vegas, Wednesday. Korea Instances picture by Kang Seung-woo
LAS VEGAS — Samsung Biologics CEO John Rim attended CES 2026 final week to discover methods for synthetic intelligence (AI)-driven digital transformation in manufacturing.
“Attending CES permits us to expertise international tendencies in superior applied sciences and achieve insights for manufacturing innovation within the AI period,” Rim mentioned.
He additionally participated in varied periods throughout CES, together with Caterpillar’s keynote, discussions on AI adoption in manufacturing and automation-based good manufacturing facility applied sciences.
Historically a client electronics and IT showcase, CES has advanced right into a broader platform encompassing AI, robotics, well being care and different industries present process digital transformation. This 12 months’s version centered on AI, digital well being and superior mobility, with specific consideration on “bodily AI” — applied sciences that allow AI programs to work together immediately with the actual world.
Nvidia CEO Jensen Huang mentioned, “One of many largest (and) most essential one is bodily AI,” whereas international companies reminiscent of Siemens and Caterpillar highlighted plans to undertake digital twin and good manufacturing facility applied sciences, emphasizing the crucial function of innovation in manufacturing.
Digital manufacturing innovation is accelerating within the pharmaceutical and biotech sectors as nicely.
Samsung Biologics has superior its manufacturing execution system and high quality execution system to supply personalized providers for international purchasers. Its lately commissioned Plant 5 employs AI and digital twin applied sciences to automate processes, optimize high quality administration and enhance productiveness. Digital manufacturing information and autonomous cellular robots additional guarantee knowledge integrity and decrease course of errors.
Following CES, Rim will attend the JP Morgan Healthcare Convention in San Francisco from Monday by means of Thursday (native time), the place he’s set to current Samsung Biologics’ digital transformation technique and long-term imaginative and prescient.
Constructing on final 12 months’s engagements, Rim may also meet with prime executives and buyers to broaden the corporate’s international community and strengthen its company credibility.
